These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9326192)

  • 1. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12.
    Oscier DG; Matutes E; Copplestone A; Pickering RM; Chapman R; Gillingham R; Catovsky D; Hamblin TJ
    Br J Haematol; 1997 Sep; 98(4):934-9. PubMed ID: 9326192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients.
    Matutes E; Oscier D; Garcia-Marco J; Ellis J; Copplestone A; Gillingham R; Hamblin T; Lens D; Swansbury GJ; Catovsky D
    Br J Haematol; 1996 Feb; 92(2):382-8. PubMed ID: 8603004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical lymphocytes in B-cell chronic lymphocytic leukemia and trisomy 12 studied by conventional staining combined with fluorescence in situ hybridization.
    Hjalmar V; Kimby E; Matutes E; Sundström C; Wallvik J; Hast R
    Leuk Lymphoma; 2000 May; 37(5-6):571-6. PubMed ID: 11042517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.
    Geisler CH; Philip P; Christensen BE; Hou-Jensen K; Pedersen NT; Jensen OM; Thorling K; Andersen E; Birgens HS; Drivsholm A; Ellegaard J; Larsen JK; Plesner T; Brown P; Andersen PK; Hansen MM
    Leuk Res; 1997; 21(11-12):1011-23. PubMed ID: 9444933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukaemia with binucleated lymphocytes.
    Amouroux I; Mossafa H; Gentilhomme O; Girot R; Flandrin G; Troussard X
    Leuk Lymphoma; 1997 Nov; 27(5-6):533-7. PubMed ID: 9477136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy.
    Cano I; Martinez J; Quevedo E; Pinilla J; Martin-Recio A; Rodriguez A; Castañeda A; López R; Pérez-Piño T; Hernández-Navarro F
    Cancer Genet Cytogenet; 1996 Sep; 90(2):118-24. PubMed ID: 8830719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia.
    Garcìa-Marco JA; Price CM; Ellis J; Morey M; Matutes E; Lens D; Colman S; Catovsky D
    Leukemia; 1996 Nov; 10(11):1705-11. PubMed ID: 8892671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisomy 12 in B-cell chronic lymphocytic leukemia: correlation with advanced disease, atypical morphology, high levels of sCD25, and with refractoriness to treatment.
    Knauf WU; Knuutila S; Zeigmeister B; Thiel E
    Leuk Lymphoma; 1995 Oct; 19(3-4):289-94. PubMed ID: 8535221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations.
    López C; Delgado J; Costa D; Conde L; Ghita G; Villamor N; Navarro A; Cazorla M; Gómez C; Arias A; Muñoz C; Baumann T; Rozman M; Aymerich M; Colomer D; Cobo F; Campo E; López-Guillermo A; Montserrat E; Carrió A
    Genes Chromosomes Cancer; 2012 Sep; 51(9):881-9. PubMed ID: 22619094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisomy 12 in chronic lymphocytic leukemia--geographical variation.
    Nair CN; Chougule A; Dhond S; Goyal R; Parikh PM; Pai S; Telang D; Advani SH
    Leuk Res; 1998 Apr; 22(4):313-7. PubMed ID: 9669836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 deletions but not trisomy 12 are adverse in B-cell lymphoproliferative disorders.
    Shaw GR; Kronberger DL
    Cancer Genet Cytogenet; 2000 Jun; 119(2):146-54. PubMed ID: 10867151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dup(12)(q13-q22) and 13q14 deletion in a case of B-cell chronic lymphocytic leukemia.
    Chena C; Sarmiento M; Palacios MF; Scolnik M; Slavutsky I
    Acta Haematol; 2000; 104(4):197-201. PubMed ID: 11279311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated 13q14 abnormalities and normal karyotypes are associated with typical lymphocyte morphology in B-cell chronic lymphocytic leukemia.
    Kroft SH; Finn WG; Kay NE; Peterson LC
    Am J Clin Pathol; 1997 Mar; 107(3):275-82. PubMed ID: 9052377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of trisomy 12, retinoblastoma gene and P53 in prognosis of B-cell chronic lymphocytic leukemia.
    AbdelSalam M; El Sissy A; Samra MA; Ibrahim S; El Markaby D; Gadallah F
    Hematology; 2008 Jun; 13(3):147-53. PubMed ID: 18702872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype.
    Schlette E; Medeiros LJ; Keating M; Lai R
    Arch Pathol Lab Med; 2003 May; 127(5):561-6. PubMed ID: 12708898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia.
    Finn WG; Thangavelu M; Yelavarthi KK; Goolsby CL; Tallman MS; Traynor A; Peterson LC
    Am J Clin Pathol; 1996 Apr; 105(4):458-67. PubMed ID: 8604688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
    Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
    Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic identification of atypical chronic lymphocytic leukemia by digital microscopy.
    Marionneaux S; Maslak P; Keohane EM
    Int J Lab Hematol; 2014 Aug; 36(4):459-64. PubMed ID: 24400650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.